Alexandria real estate equities, inc., at the vanguard of providing high-quality office/laboratory space to meet historic-high demand from the life science industry, reports: 2q21 and 1h21 net income per share - diluted of $2.61 and $2.74, respectively; 2q21 and 1h21 ffo per share - diluted, as adjusted, of $1.93 and $3.84, respectively